Bromfenac (Duract)-associated hepatic failure requiring liver transplantation - Wikidata - awgldk - TriplyDB

Bromfenac (Duract)-associated hepatic failure requiring liver transplantation

Bromfenac (Duract)-associated hepatic failure requiring liver transplantation

http://www.wikidata.org/entity/Q28370702

about

sameAs

Information about ADRs explored by pharmacovigilance approaches: a qualitative review of studies on antibiotics, SSRIs and NSAIDs Idiosyncratic drug-induced liver injury and the role of inflammatory stress with an emphasis on an animal model of trovafloxacin hepatotoxicity Mechanisms of drug-induced liver injury.Application of a Mechanistic Model to Evaluate Putative Mechanisms of Tolvaptan Drug-Induced Liver Injury and Identify Patient Susceptibility Factors.Ophthalmic utility of topical bromfenac, a twice-daily nonsteroidal anti-inflammatory agent.Hepatotoxicity and hepatic metabolism of available drugs: current problems and possible solutions in preclinical stages.Managing the challenge of chemically reactive metabolites in drug development.Drug reaction with eosinophilia and systemic symptoms: is cutaneous phenotype a prognostic marker for outcome? A review of clinicopathological features of 27 cases.Cutaneous drug reactions in children: an update.Application of urine proteomics for biomarker discovery in drug-induced liver injury.Profiling cumulative proportional reporting ratios of drug-induced liver injury in the FDA Adverse Event Reporting System (FAERS) database.Mechanistic Modelling of Drug-Induced Liver Injury: Investigating the Role of Innate Immune Responses.Update on twice-daily bromfenac sodium sesquihydrate to treat postoperative ocular inflammation following cataract extraction.Non-steroidal anti-inflammatory drugs: What is the actual risk of liver damage?Computational chemistry approach for the early detection of drug-induced idiosyncratic liver toxicity.Antimicrobial activity of untypical lipid compounds in the cuticular and internal lipids of four fly species.Necessary, but Not Sufficient. The Benefit Concept in the Project Evaluation of Animal Research in the Context of Directive 2010/63/EU.Analgesics and Antipyretics

P2860

Q33414008-05A26A2E-F3DE-4264-BBD4-B1FB36CBF3F9 Q33414008-B456D133-4A3A-4C18-B4AD-88B30E87D3C4 Q34200596-E97D2331-07B4-4BB9-BD79-21DA90866721 Q36439183-07217B8F-8C60-45F3-A4CB-90000BFCF8F0 Q37564187-0A2268DB-1D7A-4AF3-922A-6701DF1F0085 Q37564187-C8B4858F-AB56-4B59-A1BD-D9263F7EC267 Q37593089-F63C6CC6-B5FC-4DD8-979E-F0993AE86E59 Q37724173-E65A6FD4-D1CE-4F4E-89CC-5086E8009FA0 Q37860142-01610E65-1439-487E-A6F3-2EA9A4B5203C Q38049184-C12365B7-1723-4356-8608-539E661026C9 Q38120676-F0E94117-6790-4F4E-A095-915470066BBD Q38255178-9B4B3DCC-56C7-4A76-848B-369326EF10CE Q38423805-EC3ED337-DC63-4013-B73B-DCC042A6F7D5 Q38725134-04E9A7FD-6F4B-48C5-8A77-AE571789A1B6 Q38725134-87386361-C141-486C-8421-FAD8631AB7DF Q42125064-62984CBE-6E9E-4085-8AC2-8AA5615F08DB Q42333984-D0170435-FF1F-4CC9-ACC9-7B3608D627BE Q45965228-9C68C6E7-6DC7-4D57-803A-F0F29F827719 Q46971191-0ECAC240-8E28-459B-95C3-F3C817D8DA89 Q55082366-3AF0FC0E-3CD8-4527-B195-DB7C6A901813 Q56113559-00C400E6-3527-48EE-AAE8-04E05F019AEC

P2860

Bromfenac (Duract)-associated hepatic failure requiring liver transplantation

http://www.wikidata.org/entity/Q28370702

description

1999 nî lūn-bûn

@nan

1999 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

1999 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

1999年の論文

@ja

1999年論文

@yue

1999年論文

@zh-hant

1999年論文

@zh-hk

1999年論文

@zh-mo

1999年論文

@zh-tw

1999年论文

@wuu

name

Bromfenac (Duract)-associated hepatic failure requiring liver transplantation

@ast

Bromfenac (Duract)-associated hepatic failure requiring liver transplantation

@en

Bromfenac (Duract)-associated hepatic failure requiring liver transplantation

@nl

type

label

Bromfenac (Duract)-associated hepatic failure requiring liver transplantation

@ast

Bromfenac (Duract)-associated hepatic failure requiring liver transplantation

@en

Bromfenac (Duract)-associated hepatic failure requiring liver transplantation

@nl

altLabel

Bromfenac

@nl

Bromfenac(Duract)-associated hepatic failure requiring liver transplantation

@en

prefLabel

Bromfenac (Duract)-associated hepatic failure requiring liver transplantation

@ast

Bromfenac (Duract)-associated hepatic failure requiring liver transplantation

@en

Bromfenac (Duract)-associated hepatic failure requiring liver transplantation

@nl

P1433

Q28370702-87A4821D-5C9F-449A-A1D8-C78A45FF17BB

P1476

Q28370702-05FF1FA3-6347-4527-8524-0B68AC7009E5

Q28370702-5C7B133A-D1FB-4A74-9498-862745EEAC76

P2093

Q28370702-2961D3EF-846D-41E8-8E4A-FE5247972DCE

Q28370702-58F23EAD-74DB-4048-BCA6-44747D722A47

Q28370702-5E669421-5612-41CD-8EDF-48E4E98E2848

Q28370702-6312B874-6CDE-489C-8BE5-9E78D32436EF

Q28370702-77C4450A-D765-44D0-B382-FBBD43D2580A

Q28370702-825F9A05-52CF-41EE-8C4C-928FA31FF244

Q28370702-9A350C4E-1D51-44BA-8BC7-D6BFC019E2E5

Q28370702-9E933EAA-2C83-4189-8FE7-2FD2C7F041DC

Q28370702-E13A46A7-7C1A-45C1-A5D1-9EB97BE88295

Q28370702-FC1BC690-D558-40D3-8B68-3E1DC9DBBCFF

P304

Q28370702-68C1564D-E406-43E2-BFAF-42ACCCF8F9E7

Q28370702-B036CB05-7ADA-4B81-9E70-4EAA737159B1

P31

Q28370702-D02AC072-A845-487D-859E-3DE5D9F4F4EA

P356

Q28370702-3F5057A2-B51F-4EB8-A8C7-08D75257222B

Q28370702-66300607-2528-41FD-AF49-E23CE773877A

P407

Q28370702-1E8CD997-BAF7-4CD3-9931-2A8E00DC6B15

P433

Q28370702-998F58BE-697A-49CE-8ABB-12C3034C7224

P478

Q28370702-B76E5BD3-D477-4FA6-AD8C-25BD2D4D88B5

P577

Q28370702-B1AB768A-218D-4B35-9A97-1477EA4E442B

P698

Q28370702-06827D56-493B-4AF7-A6EA-9551D4A43AD6

P921

Q28370702-15BD4DB8-630D-4BF8-B539-42949F5C0CEE

P356

S0002-9270(99)00377-9

J.1572-0241.1999.01321.X

P1433

The American Journal of Gastroenterology

P1476

Bromfenac (Duract)-associated hepatic failure requiring liver transplantation

@en

Bromfenac(Duract)-associated hepatic failure requiring liver transplantation

@en

P2093

C W Pinson

http://www.w3.org/2001/XMLSchema#string

C. Wright Pinson

http://www.w3.org/2001/XMLSchema#string

E B Hunter

http://www.w3.org/2001/XMLSchema#string

Ellen B. Hunter

http://www.w3.org/2001/XMLSchema#string

G Tanner

http://www.w3.org/2001/XMLSchema#string

Gordon Tanner

http://www.w3.org/2001/XMLSchema#string

J A Awad

http://www.w3.org/2001/XMLSchema#string

Joseph A. Awad

http://www.w3.org/2001/XMLSchema#string

P E Johnston

http://www.w3.org/2001/XMLSchema#string

Philip E. Johnston

http://www.w3.org/2001/XMLSchema#string

P304

2299-2301

http://www.w3.org/2001/XMLSchema#string

2299-301

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/S0002-9270(99)00377-9

http://www.w3.org/2001/XMLSchema#string

10.1111/J.1572-0241.1999.01321.X

http://www.w3.org/2001/XMLSchema#string

P407

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

94

http://www.w3.org/2001/XMLSchema#string

P577

1999-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

10445569

http://www.w3.org/2001/XMLSchema#string

P921

liver transplantation